Background: The COVID-19 pandemic is a global emergency. AEFIs reporting and assessment should be done with high priority as they could change the benefit-risk profile of the vaccine. Objective: To assess adverse effects after COVID-19 vaccination. Methods: This cross-sectional study conducted among 605 heath functionaries taken part from January 2021 to March 2021. Results: The most common AEFI reported was pain at injection site (51.9%). Gender, previous COVID status and perception before vaccination were significantly associated with AEFI. Conclusion: There was no serious adverse event after vaccination. COVID vaccine has a good safety profile
Introduction: On 11th March 2020, the COVID-19 outbreak has been disclosed by World Health Organisat...
Introduction: Indian drug regulation authorities issued emergency approval to two vaccines and start...
Objectives: The fastidious development of the COVID-19 vaccine is a vital achievement for the countr...
Background: Covid-19, an infection caused by SARS- CoV2 has claimed millions of lives since late 201...
Background: The COVID-19 vaccination program was introduced in India on 16 January 2021. The Governm...
Background: The Oxford-AstraZeneca vaccine (Covishield) was the first to be introduced in Bangladesh...
Background: The focus of this study was on any COVID-19 vaccines adverse effects, as well as percept...
Background: The focus of this study was on any COVID-19 vaccines adverse effects, as well as percept...
Background: - COVID-19 is the most important public health problem of recent time. Many people requi...
Vaccines for COVID-19 in India have been allowed to be administered among large pool of adult popula...
Introduction: COVID-19 is a viral disease due to the Severe Acute Respiratory Syndrome Coronavirus 2...
Background: Success of an immunization programme depends upon awareness regarding usefulness and saf...
ABSTRACT: Background: SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) is a recently de...
Background: SARS-CoV-2 pandemic has affected the whole world and India is one among the most affecte...
Objective: Government of India (GOI) has allowed vaccination for age group of 15-18 y. It is a posit...
Introduction: On 11th March 2020, the COVID-19 outbreak has been disclosed by World Health Organisat...
Introduction: Indian drug regulation authorities issued emergency approval to two vaccines and start...
Objectives: The fastidious development of the COVID-19 vaccine is a vital achievement for the countr...
Background: Covid-19, an infection caused by SARS- CoV2 has claimed millions of lives since late 201...
Background: The COVID-19 vaccination program was introduced in India on 16 January 2021. The Governm...
Background: The Oxford-AstraZeneca vaccine (Covishield) was the first to be introduced in Bangladesh...
Background: The focus of this study was on any COVID-19 vaccines adverse effects, as well as percept...
Background: The focus of this study was on any COVID-19 vaccines adverse effects, as well as percept...
Background: - COVID-19 is the most important public health problem of recent time. Many people requi...
Vaccines for COVID-19 in India have been allowed to be administered among large pool of adult popula...
Introduction: COVID-19 is a viral disease due to the Severe Acute Respiratory Syndrome Coronavirus 2...
Background: Success of an immunization programme depends upon awareness regarding usefulness and saf...
ABSTRACT: Background: SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) is a recently de...
Background: SARS-CoV-2 pandemic has affected the whole world and India is one among the most affecte...
Objective: Government of India (GOI) has allowed vaccination for age group of 15-18 y. It is a posit...
Introduction: On 11th March 2020, the COVID-19 outbreak has been disclosed by World Health Organisat...
Introduction: Indian drug regulation authorities issued emergency approval to two vaccines and start...
Objectives: The fastidious development of the COVID-19 vaccine is a vital achievement for the countr...